31 articles
David Longo, Co-Founder and CEO of Ordaōs, an AI-driven drug design company, discusses generative AI and how Ordaos is using AI to design novel and cus...
Caring Cross is a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and ensuring access to cures for all patients, ev...
Mark Varney, Ph.D., Chief Scientific Officer of PsychoGenics, an AI-enabled phenotypic drug discovery and preclinical contract research organization (CR...
Jeff Bova, Chief Commercial Officer at UroGen Pharma discusses the launch of their first FDA-approved treatment, the only non-surgical option for patien...
Jared Silver, MD, PhD, Allergist Immunologist & Indication Lead for Mepolizumab, US Medical Affairs Respiratory at GSK discusses the recent FDA approval...
Most people who suffer a stroke aren’t treated in time to prevent long-term and often permanent effects on speech, cognition and motor function.
John Orwin, President and CEO of Atreca, a biopharmaceutical company, discusses their drug Discovery Platform and how they are thinking differently abou...
David Vossler, MD, FAAN FACNS FAES, Department of Neurology, University of Washington, discusses the recent U.S. Learn more on Health Professional Radio.
Raymond Douglas, an oculoplastic surgeon, discusses the approval of TEPEZZA™ (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED), the f...
Gustavo Alva, psychiatrist, discusses mood episodes, such as depression, mixed episodes, and mania, why diagnosing bi-polar disorder remains challenging...